The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guillet, M.
Right arrow Articles by Soulillou, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guillet, M.
Right arrow Articles by Soulillou, J.-P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2002, 168: 5088-5095.
Copyright © 2002 by The American Association of Immunologists

Different Qualitative and Quantitative Regulation of V{beta} TCR Transcripts During Early Acute Allograft Rejection and Tolerance Induction1

Marina Guillet*, Sophie Brouard*, Katia Gagne*, Fabien Sébille*, Maria-Cristina Cuturi*, Marc-André Delsuc{dagger} and Jean-Paul Soulillou2,*

* Institut National de la Santé et de la Recherche Médical, Unité 437, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France; and {dagger} Center de Biochimie Structurale, Faculté de Pharmacie, Montpellier, France


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Recently, using a global method of T cell repertoire analysis, we showed that purified naive T cells confronted in vitro with allogeneic APCs in a direct pathway-restricted MLR up-regulate their V{beta} mRNAs without exhibiting skewing of complementarity-determining region 3 (CDR3) length distribution. In this report, using this approach, we show in vivo that V{beta} transcript regulation and CDR3 length distribution follow the same pattern during acute rejection of MHC-incompatible heart allografts. In contrast, in tolerance induction by priming of recipients with donor cells, the vigorous V{beta} mRNA accumulation with Gaussian CDR3 length distribution is abolished, providing a possible explanation for the down-regulation of activated T cells in tolerant animals. In addition, tolerated grafts harbor T cells with a highly altered repertoire, suggestive of self-restricted presentation with some patterns corresponding to previously identified regulatory cells.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Although T cells require multiple cosignals to induce clonal expansion and maturation into effector cells, the initial selection of committed cells that follows TCR interaction with processed peptides presented on MHC molecules is the major event of a T cell-mediated response. This TCR selection can be followed by the analysis of altered TCR clonotypic patterns or complementarity-determining region 3 (CDR3)3 sequences (1). Such qualitative analyses (Immunoscope/Spectratype) have provided us with important information in various experimental and clinical situations, including autoimmune (2), infectious (3, 4), and lymphoproliferative (5) diseases. However, they are limited by several constraints. First, due to the variety of MHC restriction determinants that in the thymus differently shape the TCR among individuals, "public" TCR alterations (i.e., those reproduced in different individuals) are rare events, usually restricted to inbred populations (1, 6). Even in such instances, epitope spreading, which develops during T cell responses in vivo (7), further complicates the TCR repertoire patterns. Moreover, the cross-reactive nature of the TCR makes difficult to define a clear structure-function relationship at the TCR level (8). Thus, our understanding of the relevance of TCR alterations should be enhanced by knowledge of the amounts of mRNA involved in these repertoire biases (9, 10). Moreover, in allorecognition the situation is further complicated by superimposing recognition of allogeneic MHC expressed by foreign APC, referred to as direct recognition (11), upon the self-restricted recognition of allogeneic peptides presented by recipient APCs, referred to as indirect recognition (12). Indeed, as for self-restricted patterns, direct recognition can trigger rapid acute rejection of allografts (13, 14).

In this paper, for the first time, we use a new global approach, referred to as TcLandscape (9, 10), to study in vivo T cell mobilization by an allograft through analysis of V{beta} mRNA transcription. Qualitative alterations of V{beta} use are correlated with the magnitude of accumulation of each V{beta} mRNA species involved in a T cell response and can be represented as a V{beta} transcriptome "landscape" for each informative time point of a T cell immune response (9, 10). Using this approach, we revisited the complex in vivo T cell response during acute rejection of heart allografts placed in unmodified recipients and during induction of tolerance by donor-specific blood transfusion (DST) in the same combination (15). We show that graft-infiltrating T cells (GITC) in acutely rejected hearts are characterized by vigorously up-regulated, but unaltered CDR3 length distribution patterns of V{beta} mRNA, also typical of the pattern observed in vitro during the strict direct recognition of foreign APC by naive T cells (9). Moreover, we show that this strong Gaussian V{beta} mRNA accumulation is inhibited in heart allografts during DST tolerance induction where highly altered V{beta} mRNA patterns are observed.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals

Adult male rats, 8–12 wk old, from the LEW.1W (RT.1u), LEW.1A (RT.1a), and LEW (RT.1l) congenic strains, were purchased from Janvier (Savigny/Orge, France).

Model of acute rejection and DST-induced tolerance of heart allografts

In most of the studies reported in this work, LEW.1W rats were used as heart and blood donors, and LEW.1A rats were used as recipients. In one study performed on day 5 of the rejection process, LEW.1W rats were used as heart recipients, and LEW.1A rats were used as donors.

Heterotopic cardiac transplantations were performed as described by Ono and Lindsey (16). DST-treated rats received i.v. injections of 1 ml donor blood, collected by cardiac puncture in a heparinized syringe (20 IU/ml), on days 14 and 7 before cardiac transplantation. In this model, untreated rats reject their grafts in 6.4 ± 0.3 days, whereas DST-treated rats become specifically tolerant, rejecting third-party, but not donor-derived, skin on day 100 (17). Graft function was evaluated daily by abdominal palpation. The first group was composed of rejected grafts from untreated animals, whereas the second group was composed of grafts from DST-induced tolerant animals. Hearts were harvested on days 1, 3, 5, and 7 (i.e., until rejection).

Comparison of the values of V{beta} or C{beta}-hypoxanthine phosphoribosyl- transferase (HPRT) ratios in spleen vs heart must be avoided, because they reflect dilution of V{beta} chain mRNAs by HPRT in the heart. Therefore, proper comparisons must use syngeneic grafts as controls. These syngeneic grafts were performed using LEW.1A rats as heart donors and recipients.

RNA extraction and cDNA synthesis

Total RNA is isolated by the guanidinium isothiocyanate procedure and purified on a cesium chloride gradient (18). RNA (10 µg) was reverse transcribed using a cDNA synthesis kit (Roche, Indianapolis, IN) and was diluted to a final volume of 100 µl.

Qualitative analysis of TCR repertoire alterations

cDNA was amplified by PCR using a C{beta} primer and one of the 20 V{beta}-specific primers (6). The amplifications were performed in a 9600 PerkinElmer Automate (PE Applied Biosystems, Foster City, CA). PCR amplification conditions were as previously described (19). Each amplification product was used for an elongation reaction using a dye-labeled C{beta} primer (6), then heat-denatured, loaded onto a 6% acrylamide-8 M urea gel, and electrophoresed for 5 h using an Applied Biosystems 373A DNA sequencer (PerkinElmer).

Immunoscope software (Institut Pasteur, Paris, France) provides distribution profiles of CDR3 lengths, in amino acids, of the amplified and elongated products (1). Each profile is composed of between seven and 11 peaks, spaced by three nucleotides, corresponding to seven to 11 possible lengths of the CDR3 region. A unique length of the CDR3 is not necessarily associated with the same sequence, and the number of transcripts with a given length of CDR3 is proportional to the area under the peak (1). Some CDR3 length increasing in some V{beta} families in the polyclonal T cell background, which shows a Gaussian profile, are defined as alterations. When an expansion is present in all or several individuals, the response is "public," whereas when it is only present in one individual, the response is defined as "private." In contrast, the absence of mRNA of a given (or several) V{beta} family is referred to as TCR restriction.

Relative quantification of V{beta} transcripts

The ABI PRISM 7700 sequence detection application program (PE Applied Biosystems) was used to detect and measure fluorescence emitted during PCR amplification of a given target sequence in a 96-well reaction plate. Data were collected during each PCR cycle, which were conducted in real-time. Direct detection of PCR products was monitored by measuring the increase in fluorescence caused by the binding of SYBR Green (PE Applied Biosystems) to dsDNA. The level of fluorescence was then directly proportional to the level of PCR product. A sample of known concentration, used to draw a standard curve, permitted measurement of the amount of target sequence in each sample. To normalize the levels of the target sequences, the quantity of each V{beta} transcript was divided by the quantity of HPRT transcripts obtained from each sample.

Each V{beta} and C{beta} standard was established by amplifying samples known to contain T cells (data not shown) using specific V{beta} and C{beta} primers (6). The products of amplification were separated electrophoretically and purified using a gel extraction kit (QIAquick Gel Extraction kit; Qiagen, Hilden, Germany). The OD260 of each standard allowed us to measure the number of copies per milliliter, using the m.w. of the cDNA. A constant amount of cDNA mixed in defined serial dilutions (107, 106, 105, 104, 103, and 102 copies/well) of each standard was amplified to draw the standard curve as described previously (20). The number of copies of the cDNA target sequence was deduced from a comparison of the measured fluorescence with this standard curve. Each sample was analyzed in duplicate.

Graphic representation of integrated qualitative and quantitative TCR alterations

For each animal, the CDR3 length profiles obtained from the Immunoscope analysis were normalized, so that the total area was equal to 1. The profiles obtained from three naive rats used as a control were measured and the mean profile for the 20 V{beta} families was used as reference. Then, for each CDR3 length profile experiment, the normalized profile was compared with the sample one, and the difference was plotted on a landscape, according to the method used by Gorochov et al. (4). Percentages of alterations are represented as a color code on the landscapes. This first analysis step only gives qualitative information, because there is no indication of the amount of V{beta} altered. To combine the qualitative alterations with the level of V{beta} mRNAs involved, the values obtained from the quantitative TaqMan analysis are included in these landscapes, where the tops of the peaks represent the amount of a given CDR3 size among each V{beta} family. MatLab software was used to compute and display the data. In the integrated landscapes, referred to as a TcLandscape (for T cell landscape) developed in our laboratory (9, 10), the x-axis displays the 20 V{beta} families analyzed. The z-axis shows the ratio of the number of V{beta} transcripts to the number of HPRT transcripts (V{beta} transcripts/HPRT transcripts). The y-axis gives the 10 possible CDR3 lengths, and colors represent the percentage of alterations. The color range is deep blue (value, -50%) to dark red (50%) and is indicated on the right of the figure. As ratio values are always higher than zero, down-regulated mRNA species are compacted to the baseline level and visually underscored by comparison with strongly accumulated V{beta} mRNA.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
TcLandscapes quantify CDR3-altered V{beta} transcripts and also detect global V{beta} mRNA regulation of nonaltered transcript populations

Most of the TCR V{beta} chain analyses were performed using qualitative methods (Immunoscope/Spectratype, the latter developed in our laboratory). However, only a combined quantitative analysis of V{beta} transcripts allows understanding the meaning of altered or unaltered V{beta} profiles. Two contrasted examples are provided in Fig. 1Go only to illustrate the type of information made available by TcLandscape analysis. These examples correspond, at the left of the figure, to highly altered repertoire found in tolerant animals (Fig. 1Go, a–c, and see During induction of DST-mediated tolerance, TCR landscapes are dominated by highly altered patterns, with down-regulation of the accumulation of unaltered V{beta} transcripts) and, at the right of the figure, to Gaussian V{beta} up-regulation following Con A stimulation (9) (Fig. 1Go, d–f).



View larger version (46K):
[in this window]
[in a new window]
  		FIGURE 1. The TcLandscape method in comparison with Immunoscope and Reperturb analyses. Two examples, one representing an altered CDR3 profile (left) and the other an unaltered one (right), are given. Immunoscope software provides distribution profiles of CDR3 lengths in amino acids (a and d). Each peak corresponds to TCR transcripts with a given CDR3 length, and an elevated peak indicates the existence of a clonal expansion (a) in the polyclonal T cell background, which shows a Gaussian profile (d). The Reperturb software (b and e) is used to further identify the alterations in CDR3 length distributions of each V{beta} family in each sample. Smooth landscapes represent an unperturbed repertoire (e), whereas landscapes where mountains (denoting overamplified peaks) and valleys (denoting underrepresented CDR3 lengths) are observed represent perturbed repertoires (b). Whereas Immunoscope analysis shows the CDR3 length distribution in a given family (a), and Reperturb allows a global assessment of this distribution in all the V{beta} families (b and e), only TcLandscape gives a visual assessment of the amount of the altered (c) or nonaltered (f) V{beta} mRNA involved. In these integrated landscapes, the x-axis displays the 20 V{beta} families analyzed. The y-axis indicates the CDR3 length distribution. The z-axis shows the V{beta}:HPRT transcript ratios. Colors represent the percentage of alteration (from green for Gaussian to red for altered profiles).

 
Immunoscope analysis (1) allows identifying, in each V{beta} family separately, modifications (Fig. 1Goa) in the Gaussian CDR3 length distribution pattern typically observed in normal animals (Fig. 1God). These CDR3 length alterations observed in some V{beta} families can be visualized in graphics (Reperturb) (4) that allow a global assessment of total V{beta} alterations (Fig. 1Go, b and e) in each sample (4). TcLandscape, by combining this qualitative study (color code) with the quantitative analysis (height of the peaks) of each V{beta} family, gives a global visual assessment of the amount of altered and unaltered V{beta} transcriptome (Fig. 1Go, c and f). For instance, in the landscape shown in Fig. 1Goc, the V{beta}18 family, although strongly altered (see Fig. 1Goa given by Immunoscope and Fig. 1Gob given by Reperturb) and thus colored red (see Materials and Methods), is slightly accumulated (see z-axis; V{beta}18:HPRT ratio for each of the 10 CDR3 length possibilities, y-axis). In contrast, Fig. 1Gof shows an example in which T cells are polyclonally activated (such patterns can be observed in Con A stimulation, or under direct MLR conditions (9)). Neither Immunoscope (Fig. 1God) nor Reperturb (Fig. 1Goe) can differentiate a resting pattern from strongly and polyclonally stimulated T cells (19). In this situation our method (Fig. 1Go, c and f) allows a global visual appreciation of the magnitude of V{beta} mRNA accumulation (z-axis) of altered and unaltered profiles.

TCR landscape patterns of resting T cells are comparable in inbred animals

Fig. 2Go shows examples of landscapes of resting splenocytes in normal adult rats. Several congenic strains sharing the complete Lewis background, but differing at their MHC loci (RT1a, RT1u, and RT1l for the LEW.1A, LEW.1W, and LEW rat examples, respectively), were studied. As shown by the V{beta}/HPRT transcript ratio reliefs (z-axis) and from their distribution on the y-axis, all patterns are Gaussian in term of CDR3 length usage, with a uniform six-nucleotide dominant length. This characteristic is also illustrated by the uniform green color of the reliefs in the graphic representation, which corresponds to <10% perturbation (very low level). This is the well-established pattern for resting T lymphocytes obtained by qualitative analyses (1). When the magnitude of mRNA amplification is considered (z-axis), an almost stereotyped topology is observed in LEW.1A rats, involving dominant V{beta}2, -4, -6, -8, -10, -14, and -19 families, with two major species (V{beta}10 and -14; Fig. 2Goa). The LEW.1W rats show typical dominant V{beta}2, -4, -5, -10, -14, and -19 families with two major species (V{beta}4 and -14; Fig. 2Gob), whereas V{beta}3, -4, -6, -12, -14, -16, and -19 families, with three other major species (V{beta}3, -6, and -14), are dominant in LEW rats (Fig. 2Goc). Thus, despite almost stereotyped topologies within an inbred strain, some differences are observed when congenic strains with different MHC are compared.



View larger version (50K):
[in this window]
[in a new window]
  		FIGURE 2. Patterns of V{beta} mRNA accumulation in resting splenocytes from normal adult rats of LEW.1A (a), LEW.1W (b), and LEW (c) congenic strains. Two representative examples (from four) are presented for each congenic strain (one on the right of the panel, the other on the left). Note that all patterns observed are Gaussian (uniform green coloration of the profiles and distribution on the y-axis), and that some differences are observed in the three different MHC congenic strains in terms of the relative numbers of mRNA among the V{beta} families. In LEW.1A rats, an almost stereotyped topology involving dominant V{beta}2, -4, -6, -8, -10, -14, and -19 families is observed (a). The LEW.1W rats show a typical dominant V{beta}2, -4, -5, -10, -14, and -19 family representation (b). The LEW rats show dominant V{beta}3, -4, -6, -12, -14, -16, and -19 families (c).

 
Acute rejection of MHC-mismatched allografts by unmodified recipients mobilizes a majority of V{beta} families of the T cell repertoire with a Gaussian CDR3 length distribution of V{beta} mRNA

First, we studied in vivo the global regulation of TCR C{beta} mRNA in rejected hearts in the LEW.1W->LEW.1A combination (through C{beta}/HPRT transcript ratios, Fig. 3Goa). During the first 3 days following transplantation, the level of C{beta} transcript accumulation in T cells of rejecting hearts was roughly of the same magnitude as that observed in T cells infiltrating syngeneic grafts (LEW.1A->LEW.1A combination) that were used as controls. Then C{beta} accumulation rose to peak on day 5 and fell at rejection, probably reflecting the extensive tissue necrosis.



View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 3. Kinetics of TCR mRNAs during acute rejection processes of heart allografts in the LEW.1W->LEW.1A combination. Hearts were harvested 1, 3, 5, and 7 days after grafting. a, The kinetics of C{beta}/HPRT transcript ratios during acute rejection of the allografts ({blacksquare}) compared with those obtained from syngeneic grafts ({square}). The level of C{beta} transcripts during the first 3 days following transplantation is roughly of the same magnitude as that observed in T cells infiltrating syngeneic grafts. Then C{beta} accumulation rises dramatically on day 5, to drop on day 7. b, The kinetics of V{beta}/HPRT transcript ratios during rejection. Each landscape is derived from an individual rat, and two representative experiments (from four) are shown. Patterns obtained on days 1, 3, 5, and 7 are shown from the top to the bottom. As shown in b, significant V{beta} mRNA accumulation is observed after day 3 and is maximum on day 5, regressing on day 7. CDR3 length patterns are Gaussian, particularly on day 5. Indeed, a few minor alterations are observed in some V{beta} families both earlier and later, as indicated by the appearance of red spots on the TcLandscape.

 
Fig. 3Gob shows, on two representative examples from four experiments, the kinetics of TCR V{beta} landscape patterns during acute heart rejection. As assessed by V{beta}/HPRT transcript ratios and fitting with the C{beta} global profile, V{beta} mRNA accumulation was observed after day 3 and was maximum on day 5 (when most of the T cell activation also takes place in this model (21, 22)), regressing on day 7. The maximum accumulation of V{beta} mRNA immediately preceded (day 5) the definitive rejection (6.4 ± 0.3 days). However, not all V{beta} family transcripts contributed similarly to the global C{beta} accumulation. Indeed, some families (V{beta}2, -4, -5, -9, -14, -15, and -16) represented most of the V{beta} accumulation, whereas others (V{beta}1, -7, -8, -18, and -20, for example) were less mobilized. Fig. 4Go shows that in the patterns observed in the reverse combination (LEW.1A->LEW.1W), the strong V{beta} mRNA accumulation observed on day 5 was also Gaussian. However, interestingly, the dominant families involved were different from those found in the LEW.1W->LEW.1A combination, indicating that V{beta} families, despite their Gaussian CDR3 profile, are not mobilized at random. Interestingly, the strong unaltered V{beta} mRNA accumulation observed in the graft on day 5 mimicked the profiles we recently observed in vitro in MLR performed in conditions only allowing the direct pathway of allorecognition to occur (9), and this suggests that direct recognition pathways are instrumental in acute allograft rejection. However, in the in vivo situation, up-regulation of V{beta} mRNA families engaged in recognition of allopeptide presented by self APC (indirect pathway of recognition) is also likely to occur, but is probably masked by the superimposed Gaussian accumulation of V{beta} transcripts. Nevertheless, a few examples of altered (CDR3 length biases) V{beta} families were detected, indicated by the appearance of red spots on the TcLandscape representation (Fig. 3Gob). However, they involved only extremely low levels of V{beta} mRNA accumulation. Two kinds of altered patterns were observed, among which very early alterations (day 1) hardly conform to a classical indirect recognition pathway for timing reasons. Those alterations probably result from the small number of T cells in the infiltrate on day 1 in allogeneic grafts, also observed in syngeneic grafts (data not shown), which may be related to a phenomenon of dilution of TCR mRNA in poorly infected hearts. Alternatively, some pre-existing memory T cells could also lead to such patterns. The second type involves minor and inconstant modifications that occur later (day 7), when the rejection process has destroyed the graft, and probably reflect the expanding self-restricted pathway of allorecognition.



View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 4. Patterns of TCR mRNA regulation in rejected hearts on day 5 in the LEW.1A->LEW.1W combination. Two representative experiments (from four) are shown. The Gaussian profile and the strong accumulation of V{beta}/HPRT transcript ratios observed in the reverse combination (LEW.1W->LEW.1A) (Fig. 3Gob) are still present, but the V{beta} families involved are different.

 
During induction of DST-mediated tolerance, TCR landscapes are dominated by highly altered patterns, with down-regulation of the accumulation of unaltered V{beta} transcripts

The kinetics of C{beta}/HPRT transcript ratios observed in DST-induced tolerance were very different from the rejecting ones, with an early and sustained mRNA accumulation until day 5, which decreased thereafter (Fig. 5Goa). The difference in mRNA accumulation between tolerant and rejecting hearts was highly significant on day 5 at the C{beta} level (p < 0.05). This difference was also observed at the level of most of the V{beta} families, as shown in Fig. 6Go, where each mRNA species (from rejecting and tolerated hearts) is compared with V{beta} transcript accumulation in syngeneic grafts. Significantly regulated V{beta} mRNA values (p < 0.05) are plotted as a filled square on a grid encompassing the entire TCR{beta} transcriptome (9). Twenty percent of the possible CDR3 lengths of the V{beta} transcripts was significantly regulated in GITC from rejecting hearts (Fig. 6Goa), whereas only 2% of the possible mRNA species underwent significant changes in DST-induced tolerance (Fig. 6Gob).



View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 5. Kinetics of TCR mRNAs during DST-induced tolerance of heart allografts. The kinetics of C{beta}/HPRT transcript ratios observed in DST-induced tolerance differs strongly from that observed in the rejection process, with an early and sustained mRNA accumulation until day 5, which decreases thereafter (a). b, Two representative experiments (from four), one on the left and the other on the right, showing the kinetics of V{beta}/HPRT transcript ratios. Strong and early CDR3 length alterations in different V{beta} families (red spots) are observed, and the ratios are modest compared with the Gaussian-type accumulation observed in rejection (b).

 


View larger version (46K):
[in this window]
[in a new window]
  		FIGURE 6. TCR V{beta} mRNA accumulation according to CDR3 lengths in infiltrating T cells from rejecting (a) and tolerating (b) hearts on day 5. The grid represents the V{beta} transcriptome (20 V{beta} families, 10 different CDR3 lengths). Dark squares correspond to mRNA species significantly up-regulated compared with the accumulation of similar mRNA species from syngeneic grafts. An estimation of the diversity of TCR V{beta} mobilized in rejection and tolerance is given by the percentage of dark squares exhibiting a significant accumulation (by Student’s t test) (see also Ref. 9 ).

 
Again, the global C{beta} profile did not reflect the complex V{beta} transcriptome patterns. Fig. 5Gob shows two representative examples from four experiments of TcLandscape of GITC of tolerated hearts following the DST induction protocol. As a first general statement, the patterns were in sharp contrast with those observed during rejection, with strong and early CDR3 length alterations in different V{beta} families. This accumulation of altered V{beta} families was highly suggestive of a self-restricted presentation pathway following DST priming (exemplified on the graph by the red peaks, which are almost absent in patterns of acute rejection in unmodified hosts, as shown in Fig. 3Gob). These altered patterns of different V{beta} families, serially observed in time, are reminiscent of a spreading-type phenomenon. Interestingly, we have previously used RNase protection assays to quantify a unique clonotypic alteration (V{beta}18 D{beta}1 J{beta}2.7), with the same CDR3 nucleotide sequence, identified in all tolerated hearts of DST-treated animals tested under the same conditions (6). TcLandscape shaped by DST also showed V{beta}18 alterations triggered by LEW.1W DST priming, with the appearance of red spots as early as day 1 following LEW.1W heart graft and sustained until day 7 (Fig. 5Gob). The possibility that such a self-restricted pattern is related to the presence of regulatory T cells that play a role in the induction of tolerance is also suggested by our recent observation that vaccination using V{beta}18-encoding cDNA abrogates the tolerance state (23). In addition, another modification observed in TCR landscapes of graft-infiltrating cells from tolerated organs is the concomitant absence of the vigorous Gaussian-type V{beta} mRNA accumulation, normally associated with the rejection process (see Fig. 3Gob, day 5). Therefore, the profile of V{beta} mRNA accumulation during tolerance induction is congruent with a down-regulation of direct stimulation. It is possible that this down-regulation precedes (and explains) the broad inhibition (involving both Th1 and Th2 cells) of T cell activation previously reported in this model of tolerance induction (21, 22).

Interestingly, the TcLandscape patterns obtained from the spleen of rejecting or tolerant hearts do not differ from those observed in naive animals (data not shown). This suggests that most of altered (potentially regulating) cells need the graft structure for differentiation and expansion.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In this report, we revisited the T cell mobilization in rejected and tolerated allografts using a combination of qualitative and quantitative assessments of all CDR3 length-restricted mRNAs in each V{beta} family. The method used has several advantages over classical qualitative approaches (9, 10). Indeed, without concomitant quantitative information, an analysis restricted to qualitative CDR3 length alterations does not discriminate polyclonal regulation (observed in Con A or superantigen stimulation) in which no CDR3 length biases are expected from a resting stage (9). Using this method, which allows quantifying both CDR3-altered and polyclonal responses, we were able to show that rejection is associated with a vigorous Gaussian accumulation of V{beta} chain mRNA in TCR GITC, whereas a down-regulation of C{beta} transcripts and a strongly altered pattern are observed in tolerated grafts.

The TcLandscape resting patterns of inbred animals are of an almost stereotyped Gaussian polyclonal type, as expected from previous studies of CDR3 length distribution in resting T cell populations (1). However, landscape topologies (V{beta} mRNA accumulation) vary somewhat among congenic rat strains with LEW background but different MHCs. These different patterns could have been shaped by thymus selection processes as well as by subtle preimmune constraints in the TCR repertoire (24). Interestingly, whereas T cell activation is characterized by a down-regulation of membranous TCR (25), TCR chain mRNA accumulation is observed (9, 26, 27). However, V{beta} transcript accumulation is the result of a composite regulation depending on both activation (26) and kinetics of T cells infiltrating the graft. In the model used in this paper, the infiltrate is maximum on day 5 during rejection and tolerance induction following DST priming (22, 28), and T cells are found at similar levels in rejected and tolerated grafts (22, 28, 29). Thus, as would also be the case for study of the transcripts of T cell-related cytokines, this approach gives an integrated value of the flux of immigrant T cells in the graft (similar in rejected and tolerant grafts (21, 22)) as well as an idea of the magnitude of their V{beta} transcription regulation.

A first important observation that emerges from this global appraisal of TCR during acute heart rejection is that strong V{beta} chain accumulation occurs in the absence of alterations of CDR3 length distribution among all tested V{beta} families. Interestingly, the Gaussian CDR3 length mRNA distribution and the transcript accumulation observed in vivo during acute rejection closely mimic what we recently described in vitro in an MLR performed to select experimental conditions of strict direct allorecognition pathway (9). This is in agreement with the fact that TCR recognition of alloligands may involve more molecular interactions with MHC framework determinants (30, 31) than in the CDR3-restricted recognition of self-MHC molecules (31, 32, 33). Such peptide-dependent (but not peptide-specific) interactions with foreign MHC framework moieties would be the basis of the high frequency of alloreactive T cells. Finally, allo-MHC molecules have been shown to elicit an alloreactive cytotoxic response even in the absence of peptide (34, 35). However, we do not exclude that the diversity and the amounts of the allodeterminants from a heart allograft could result in a polyclonal-type pattern. The unaltered CDR3 patterns observed during the rejection process are in agreement with the hypothesis of an unexpected proportion of responding naive T cells, possibly amplified by TCR cross-reaction (8). However, and in contrast to direct-restricted MLR, both direct and indirect pathways are involved in vivo during acute rejection (14). It is therefore possible that the expected altered pattern of self-restricted allorecognition that develops when an acellular extract of allogeneic tissue is injected into a LEW.1A rat (9) is masked by the vigorous Gaussian (direct-type) response observed in rejection, or that it has not had time to occur due to the rapid rejection process (days 6 and 7). Our observations allow a better understanding of why the response of a naive (i.e., unprimed) recipient against a graft is so vigorous and can result in a definitive acute rejection of a large transplant within a very short time (6–7 and 5 days for heart and kidney allografts, respectively, in this combination). In fact, a large proportion of T cells driven by the direct recognition pathway are probably involved in this process, whereas only a few specifically committed T cells, with a strongly altered TCR pattern that depends on self-restricted presentation by self APC, would be involved in the delayed or chronic rejection process, as observed in both rats (19) and humans (20). However, not all V{beta} family mRNAs are overexpressed. Some families have unchanged mRNA levels, contrasting with the strong accumulation of others, and the profiles, despite Gaussian, are not produced randomly.

In contrast to the acute rejection, the patterns exhibited by tolerated hearts following DST are strongly altered, suggesting the development of a recall indirect pathway type of T cell response following transplantation after DST priming. This interpretation is in agreement with the early kinetics of these TCR alterations, present as early as day 3, with strongly altered patterns on day 5, in contrast to the Gaussian activation profile observed in rejected hearts at the same time. In addition, and possibly instrumental in the mechanism of graft acceptance, the vigorous day 5 Gaussian V{beta} mRNA accumulation consistently observed in unmodified rejecting recipients is inhibited in DST-primed rats despite a strong T cell infiltrate (22, 36) and the absence of clonal deletion of specific alloreactive cells in this model (37, 38). This pattern fits with (and possibly controls) the inhibition of Th1- and Th2-related cytokines observed on day 5 following transplantation in this model of tolerance induction (21, 22). The idea that the T cells with altered CDR3 length distribution that accumulate in tolerated hearts are regulatory cells is an attractive possibility. Graft-resident dendritic cells, the only class II+ APC of normal rat hearts (39), are likely to be involved in this process, as they have been shown to be required in the graft for tolerance induction following DST (40). Alternatively, putative regulatory cells with strongly skewed V{beta} usage may regulate the capacity of graft dendritic cells to stimulate naive T cells. Indeed, regulatory T cell clones can also impact on stimulating properties of APC (11). A role for these clones is shown by the fact that vaccination using the plasmid encoding V{beta}18 cDNA, one of the most strongly altered families (6), with identical CDR3 sequences, found in DST-treated recipients from days 1–7 (Fig. 5Go), prevents tolerance induction in this model (23). Interestingly, the altered patterns were only found in the heart and not in the spleen. This is in agreement with the concept that regulatory T cells require the presence of the tolerated tissues. Indeed, only retransplantation of the tolerated allogeneic tissue into T cell-deprived mice restores T cells with regulatory capabilities (41). The exact mechanism of such regulation remains elusive. However, our data cannot rule out the possibility that other T cell subsets, such as memory or effector cells, are also present in the graft and contribute to build the altered profiles observed. Indeed, despite the findings that DST-treated tolerant recipients can specifically accept a LEW.1A skin graft and can, as described in the model used by Zhai et al. (42), generate splenocytes able to transfer tolerance to naive hosts, they nevertheless present unambiguous chronic rejection at histological examination over the long term (K. Renaudin and R. Josien, manuscript in preparation), indicating that the two populations may coexist.


   Acknowledgments
 
We thank H. Smit, V. Proust, and C. Usual for performing the rat heterotopic allotransplantations, and J. M. Heslan for technical help with real-time PCR. We thank G. Benichou (Harvard Medical School, Boston, MA), A. Saoudi (Institut National de la Santé et de la Recherche Médical, Unité 28, Toulouse, France), B. Rocha (Institut National de la Santé et de la Recherche Médical, Unité 345, Paris, France), and R. Josien (Institut National de la Santé et de la Recherche Médical, Unité 437, Nantes, France) for discussion of the data and criticism of the manuscript.


   Footnotes
 
1 This work was supported in part by Fondation Transvie, Société Française de Transplantation, Etablissement Français des Greffes, and Association Française de Lutte contre la Mucoviscidose. Back

2 Address correspondence and reprint requests to Dr. Jean-Paul Soulillou, Institut National de la Santé et de la Recherche Médical, Unité 437, 30 boulevard Jean Monnet, 44093 Nantes Cedex 01, France. E-mail address: jps{at}nantes.inserm.fr Back

3 Abbreviations used in this paper: CDR3, complementarity-determining region 3; DST, donor-specific transfusion; GITC, graft-infiltrating T cell; HPRT, hypoxanthine phosphoribosyltransferase; LDA, limiting dilution assay; LEW, Lewis. Back

Received for publication January 7, 2002. Accepted for publication March 8, 2002.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Pannetier, C., J. Even, P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.[Medline]
  2. Fillion, J., R. Baccala, C. Pannetier, J. Kuhn, P. Druet, B. Bellon. 1997. Evidence for heterogeneous TCR V{beta} repertoire expression in mercury-induced immune disorders in rats. Int. Immunol. 9:263.[Abstract/Free Full Text]
  3. Silins, S. L., S. M. Cross, K. G. Krauer, D. J. Moss, C. W. Schmidt, I. S. Misko. 1998. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J. Clin. Invest. 102:1551.[Medline]
  4. Gorochov, G., A. U. Neumann, A. Kereveur, C. Parizot, T. Li, C. Katlama, M. Karmochkine, G. Raguin, B. Autran, P. Debre. 1998. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat. Med. 4:215.[Medline]
  5. Puisieux, I., J. Even, C. Pannetier, F. Jotereau, M. Favrot, P. Kourilsky. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807.[Abstract]
  6. Douillard, P., C. Pannetier, R. Josien, S. Menoret, P. Kourilsky, J. P. Soulillou, M. C. Cuturi. 1996. Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-V{beta} rearrangement in heart allografts. J. Immunol. 157:1250.[Abstract]
  7. Suciu-Foca, N., P. E. Harris, R. Cortesini. 1998. Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol. Rev. 164:241.[Medline]
  8. Mason, D.. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395.[Medline]
  9. Sebille, F., K. Gagne, M. Guillet, N. Degauque, A. Pallier, S. Brouard, B. Vanhove, M. A. Delsuc, J. P. Soulillou. 2001. Direct recognition of foreign MHC determinants by naive T cells mobilizes specific V{beta} families without skewing of the complementarity-determining region 3 length distribution. J. Immunol. 167:3082.[Abstract/Free Full Text]
  10. Guillet, M., F. Sebille, J. Soulillou. 2001. TCR usage in naive and committed alloreactive cells: implications for the understanding of TCR biases in transplantation. Curr. Opin. Immunol. 13:566.[Medline]
  11. Lechler, R. I., G. Lombardi, J. R. Batchelor, N. Reinsmoen, F. H. Bach. 1990. The molecular basis of alloreactivity. Immunol. Today 11:83.[Medline]
  12. Benichou, G., P. A. Takizawa, C. A. Olson, M. McMillan, E. E. Sercarz. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175:305.[Abstract/Free Full Text]
  13. Pietra, B. A., A. Wiseman, A. Bolwerk, M. Rizeq, R. G. Gill. 2000. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106:1003.[Medline]
  14. Benichou, G., A. Valujskikh, P. S. Heeger. 1999. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162:352.[Abstract/Free Full Text]
  15. Soulillou, J. P., F. Blandin, E. Gunther, V. Lemoine. 1984. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 38:63.[Medline]
  16. Ono, K., E. Lindsey. 1967. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 57:225.[Medline]
  17. Douillard, P., C. Vignes, R. Josien, E. Chiffoleau, J. M. Heslan, V. Proust, J. P. Soulillou, M. C. Cuturi. 1999. Reassessment of the role of CD8+ T cells in the induction of allograft tolerance by donor-specific blood transfusion. Eur. J. Immunol. 29:1919.[Medline]
  18. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.[Medline]
  19. Brouard, S., B. Vanhove, K. Gagne, A. Neumann, P. Douillard, A. Moreau, C. Cuturi, J. P. Soulillou. 1999. T cell repertoire alterations of vascularized xenografts. J. Immunol. 162:3367.[Abstract/Free Full Text]
  20. Gagne, K., S. Brouard, M. Giral, F. Sebille, A. Moreau, M. Guillet, J. D. Bignon, B. M. Imbert, M. C. Cuturi, J. P. Soulillou. 2000. Highly altered V{beta} repertoire of T cells infiltrating long-term rejected kidney allografts. J. Immunol. 164:1553.[Abstract/Free Full Text]
  21. Bugeon, L., M. C. Cuturi, M. M. Hallet, J. Paineau, D. Chabannes, J. P. Soulillou. 1992. Peripheral tolerance of an allograft in adult rats: characterization by low interleukin-2 and interferon-{gamma} mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 54:219.[Medline]
  22. Josien, R., C. Pannetier, P. Douillard, D. Cantarovich, S. Menoret, L. Bugeon, P. Kourilsky, J. P. Soulillou, M. C. Cuturi. 1995. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 60:1131.[Medline]
  23. Vignes, C., E. Chiffoleau, P. Douillard, R. Josien, H. Peche, J. M. Heslan, C. Usal, J. P. Soulillou, M. C. Cuturi. 2000. Anti-TCR-specific DNA vaccination demonstrates a role for a CD8+ T cell clone in the induction of allograft tolerance by donor-specific blood transfusion. J. Immunol. 165:96.[Abstract/Free Full Text]
  24. Wallace, M. E., M. Bryden, S. C. Cose, R. M. Coles, T. N. Schumacher, A. Brooks, F. R. Carbone. 2000. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity 12:547.[Medline]
  25. Jose, E. S., B. Alarcon. 1999. Receptor engagement transiently diverts the T cell receptor heterodimer from a constitutive degradation pathway. J. Biol. Chem. 274:33740.[Abstract/Free Full Text]
  26. Lennon, G. P., J. E. Sillibourne, E. Furrie, M. J. Doherty, R. A. Kay. 2000. Antigen triggering selectively increases TCRBV gene transcription. J. Immunol. 165:2020.[Abstract/Free Full Text]
  27. Paillard, F., G. Sterkers, G. Bismuth, E. Gomard, C. Vaquero. 1988. Lymphokine mRNA and T cell multireceptor mRNA of the Ig super gene family are reciprocally modulated during human T cell activation. Eur. J. Immunol. 18:1643.[Medline]
  28. Armstrong, H. E., E. M. Bolton, I. McMillan, S. C. Spencer, J. A. Bradley. 1987. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J. Exp. Med. 165:891.[Abstract/Free Full Text]
  29. Dallman, M. J., K. J. Wood, P. J. Morris. 1987. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J. Exp. Med. 165:566.[Abstract/Free Full Text]
  30. Daniel, C., S. Horvath, P. M. Allen. 1998. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity 8:543.[Medline]
  31. Brock, R., K. H. Wiesmuller, G. Jung, P. Walden. 1996. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc. Natl. Acad. Sci. USA 93:13108.[Abstract/Free Full Text]
  32. Garcia, K. C., M. Degano, L. R. Pease, M. Huang, P. A. Peterson, L. Teyton, I. A. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166.[Abstract/Free Full Text]
  33. Speir, J. A., K. C. Garcia, A. Brunmark, M. Degano, P. A. Peterson, L. Teyton, I. A. Wilson. 1998. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity 8:553.[Medline]
  34. Fink, P. J., H. G. Rammensee, M. J. Bevan. 1984. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J. Immunol. 133:1775.[Abstract]
  35. Smith, P. A., A. Brunmark, M. R. Jackson, T. A. Potter. 1997. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185:1023.[Abstract/Free Full Text]
  36. Dallman, M. J., O. Shiho, T. H. Page, K. J. Wood, P. J. Morris. 1991. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J. Exp. Med. 173:79.[Abstract/Free Full Text]
  37. Bugeon, L., M. C. Cuturi, J. Paineau, I. Anegon, J. P. Soulillou. 1993. Similar levels of granzyme A and perforin mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 56:405.[Medline]
  38. Roelen, D. L., A. R. Bushell, M. Niimi, N. T. Young, N. A. Rust, P. J. Morris, K. J. Wood. 1998. Immunoregulation by CD4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo: evidence for a reduction in the frequency of alloantigen-specific cytotoxic T cells in vitro. Hum. Immunol. 59:529.[Medline]
  39. Forbes, R. D., N. A. Parfrey, M. Gomersall, A. G. Darden, R. D. Guttmann. 1986. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection. J. Exp. Med. 164:1239.[Abstract/Free Full Text]
  40. Josien, R., M. Heslan, S. Brouard, J. P. Soulillou, M. C. Cuturi. 1998. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood. 92:4539.[Abstract/Free Full Text]
  41. Waldmann, H., S. Cobbold. 2001. Regulating the immune response to transplants: a role for CD4+ regulatory cells?. Immunity 14:399.[Medline]
  42. Zhai, Y., X. D. Shen, M. Lehmann, R. Busuttil, H. D. Volk, J. W. Kupiec-Weglinski. 2001. T cell subsets and in vitro immune regulation in "infectious" transplantation tolerance. J. Immunol. 167:4814.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
P. Wettstein, M. Strausbauch, T. Therneau, and N. Borson
The application of real-time PCR to the analysis of T cell repertoires
Nucleic Acids Res., December 1, 2008; 36(21): e140 - e140.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
P. J. Wettstein, M. Strausbauch, and N. Borson
Repertoires of T cell receptors expressed by graft-infiltrating T cells evolve during long-term recall responses to single minor histocompatibility antigens
Int. Immunol., April 1, 2007; 19(4): 523 - 534.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
N. Najafian, M. J. Albin, and K. A. Newell
How Can We Measure Immunologic Tolerance in Humans?
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2652 - 2663.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Duplan, G. Beriou, J.-M. Heslan, C. Bruand, P. Dutartre, L. T. Mars, R. S. Liblau, M.-C. Cuturi, and A. Saoudi
LF 15-0195 Treatment Protects against Central Nervous System Autoimmunity by Favoring the Development of Foxp3-Expressing Regulatory CD4 T Cells
J. Immunol., January 15, 2006; 176(2): 839 - 847.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. L. Sumpter and D. S. Wilkes
Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1129 - L1139.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D.-A. Laplaud, C. Ruiz, S. Wiertlewski, S. Brouard, L. Berthelot, M. Guillet, B. Melchior, N. Degauque, G. Edan, P. Brachet, et al.
Blood T-cell receptor {beta} chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution
Brain, May 1, 2004; 127(5): 981 - 995.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guillet, M.
Right arrow Articles by Soulillou, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guillet, M.
Right arrow Articles by Soulillou, J.-P.
Right arrowPubmed/NCBI databases
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS